Skip to main content
Federal Practitioner
FULL MENU
FULL MENU
/
Federal Practitioner
CE/CME
Cardiology
Diabetes
Federal News
Government and Regulations
Health Policy
News
Journal
Digital Edition/App
Current Regular Issue
Current Special Issue
Past Issues
Submission Guidelines
Mental Health
Oncology
AVAHO Updates
Breast Cancer
Colon and Rectal
Hematologic Malignancies
Lung Cancer
Oncology
Prostate Cancer
Pharmacology
Women's Health
Government and Regulations
Nerve Agent Linked to Brain Cancer
Fed Pract
. 2005 September;22(9):31
PDF Download
Recommended Reading
Avoiding VTE in Cancer
Federal Practitioner
HRT and Ovarian Cancer: How Does Dose Affect Risk?
Federal Practitioner
Alcohol Withdrawal in Terminal Cancer
Federal Practitioner
When It's Time to Stop Cancer Treatment: Helping Patients Prepare for Death
Federal Practitioner
Ileal Carcinoid Tumor
Federal Practitioner
Anticancer Drug Aces Phase III Trial
Federal Practitioner
New Management Strategies for HPV
Federal Practitioner
Don't Neglect this Prostate Cancer Test
Federal Practitioner
Bicalutamide Benefits in Prostate Cancer
Federal Practitioner
Finasteride and Prostate Cancer Development
Federal Practitioner
Oncology
FULL MENU
FULL MENU
MDedge Home
Diseases & Conditions
Depression
Diabetes
Hepatitis
HIV
Long COVID
Obesity
Pain
PTSD
Stroke
Traumatic Brain Injury
Hematology and Oncology
AVAHO Updates
Breast Cancer
Colon and Rectal
Hematologic Malignancies
Lung Cancer
Oncology
Prostate Cancer
Specialties
Addiction Medicine
Cardiology
Dermatology
Geriatrics
Mental Health
Neurology
Orthopedics
Pharmacology
Pulmonology
Sexual Health
Sleep Medicine
Trauma
Vaccines
Women's Health
Federal News
Government and Regulations
Health Policy
News
Original Articles
Case Reports
Original Research
Reviews
Best Practices
Clinical Review
Perspectives
Commentary
Q&A
Diversity in Medicine
Explore
Multimedia
Explore
Audio
Video
Blood & Cancer podcast
Dermatology Weekly podcast
Psychcast podcast
All MDedge podcasts
News
Explore
News by Conference
Expert Interview
For Residents
Quizzes
Explore
MD-IQ
CME Supplements
ReCAP
Conference ReCAP
Supplements
Sponsored Content
Explore
Treatment of Veterans With Metastatic Hormone-Sensitive Prostate Cancer
Research Summaries
Explore
Clinical Edge Journal Scan
Roundtables
CE/CME
Submission Guidelines
Subscribe to Federal Practitioner
Treatment of Veterans With Metastatic Hormone-Sensitive Prostate Cancer
Medical Directors / Pharmacy Directors
Nurse Practitioners / Physician Assistants
Residents
VA / DoD / PHS
MDedge Home
Diseases & Conditions
Depression
Diabetes
Hepatitis
HIV
Long COVID
Obesity
Pain
PTSD
Stroke
Traumatic Brain Injury
Hematology and Oncology
AVAHO Updates
Breast Cancer
Colon and Rectal
Hematologic Malignancies
Lung Cancer
Oncology
Prostate Cancer
Specialties
Addiction Medicine
Cardiology
Dermatology
Geriatrics
Mental Health
Neurology
Orthopedics
Pharmacology
Pulmonology
Sexual Health
Sleep Medicine
Trauma
Vaccines
Women's Health
Federal News
Government and Regulations
Health Policy
News
Original Articles
Case Reports
Original Research
Reviews
Best Practices
Clinical Review
Perspectives
Commentary
Q&A
Diversity in Medicine
Explore
Multimedia
Explore
Audio
Video
Blood & Cancer podcast
Dermatology Weekly podcast
Psychcast podcast
All MDedge podcasts
News
Explore
News by Conference
Expert Interview
For Residents
Quizzes
Explore
MD-IQ
CME Supplements
ReCAP
Conference ReCAP
Supplements
Sponsored Content
Explore
Treatment of Veterans With Metastatic Hormone-Sensitive Prostate Cancer
Research Summaries
Explore
Clinical Edge Journal Scan
Roundtables
CE/CME
Submission Guidelines
Subscribe to Federal Practitioner
Treatment of Veterans With Metastatic Hormone-Sensitive Prostate Cancer
Medical Directors / Pharmacy Directors
Nurse Practitioners / Physician Assistants
Residents
VA / DoD / PHS